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Background: The Genome Variant Format (GVF) uses the Sequence Ontology (SO) to enable detailed annotation of
sequence variation. The annotation includes SO terms for the type of sequence alteration, the genomic features
that are changed and the effect of the alteration. The SO maintains and updates the specification and provides the
underlying ontologicial structure.
Methods: A requirements analysis was undertaken to gather terms missing in the SO release at the time, but
needed to adequately describe the effects of sequence alteration on a set of variant genomic annotations. We have
extended and remodeled the SO to include and define all terms that describe the effect of variation upon
reference genomic features in the Ensembl variation databases.
Results: The new terminology was used to annotate the human reference genome with a set of variants from
both COSMIC and dbSNP. A GVF file containing 170,853 sequence alterations was generated using the SO
terminology to annotate the kinds of alteration, the effect of the alteration and the reference feature changed.
There are four kinds of alteration and 24 kinds of effect seen in this dataset. (Ensembl Variation annotates 34
different SO consequence terms: http://www.ensembl.org/info/docs/variation/predicted_data.html).
Conclusions: We explain the updates to the Sequence Ontology to describe the effect of variation on existing
reference features. We have provided a set of annotations using this terminology, and the well defined GVF
specification. We have also provided a provisional exploration of this large annotation dataset.Findings
Background
The Sequence Ontology (SO) [1] provides terminology
to define sequence features. These features are the build-
ing blocks of sequence annotation, and allow biologically
meaningful regions to be assigned between coordinates
of sequences such as genome assemblies and transcripts.
The relationships between the terms in SO provide for
the annotation of multi-part features such as gene
models, composed of multiple transcripts, exons, introns
and UTR features. Reference genome annotations are
often shared using a flat file format GFF3, developed by
the GMOD community [2], which stipulates that SO
terms describe each annotated feature, thus many gen-
ome annotation tools use SO to describe reference gen-
ome features. While terms to describe variants have long* Correspondence: keilbeck@genetics.utah.edu
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new variation terms to describe the predicted effect of
sequence alterations on existing genomic features lead
to the development of new terms. This has been driven
by the proliferation of software tools that predict the ef-
fect of sequence alterations such as Ensembl’s Variant
Effect Predictor (VEP) [3] and the VAAST suite tool:
Variant Annotation Tool (VAT) [4]. In this mansucript,
SO terms are italicized and written without underscores.
Next generation sequencing (NGS) technologies have
provided an enormous expansion in our understanding
of the landscape of genetic variation [5, 6] as well as the
impact of that variation on human health [7–9]. These
datasets create a significant burden in computational
analysis and data storage, but established work-flows for
analysis are emerging [3] and well established data for-
mats exist for each stage of the process. The original
base calls from the sequencer are converted to FASTQ
files [10] that contain the sequence data; the SAM for-
mat [11] captures the alignment of the sequence to acess article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Cunningham et al. Journal of Biomedical Semantics  (2015) 6:32 Page 2 of 5reference genome and the Variant Call Format [12] has
become widely adopted by variant calling tools to report
variants and the information needed to call them. How-
ever, knowing the type and genomic location of a se-
quence change is just the first step in understanding its
clinical or biological consequences. Variant annotation
then begins the process of adding additional knowledge
about the structural and functional consequences of
those variants through the impact on reference sequence
features and ultimately on phenotype.
The Genome Variation Format (GVF) [13] is a variant
file format for the detailed annotation of genetic vari-
ation. GVF is a community supported format that uses
established ontologies such as the Sequence Ontology
[1] to describe the variant data. GVF does not replace
existing variant nomenclature systems such as HGVS
[14] and ISCN [15] that provide effective ways to unam-
biguously describe individual variants in the literature.
GVF provides the infrastructure to support inclusion of
these nomenclatures along with other detailed variant
annotations in a format capable of supporting genome
scale variant data. GVF is used in the community for ex-
change of variant annotations between Ensembl [16],
DGVa and dbVar [17] and is compatible with existing
GFF3 software [2, 18] as well as emerging domain spe-
cific tools [4, 19].Fig. 1 Hierarchical view of new and modified Sequence Ontology terms u
portion of the SO sequence variant subsumption hierarchy is shown, with t
where the sequence alteration occurs within or overlaps an annotated refe
ablation, feature amplification, define cases where an entire feature is altere
http://sequenceontology.org/browser/obob.cgi and http://ensembl.org/infoUser requirements and ontology development
Upon the release of the specification for variant genome
annotation, GVF used terms from the Sequence Ontol-
ogy release 2.4.3. While this resource provided 101
terms to describe the effects of a sequence alteration on
genomic features, it was still missing sufficiently special-
ized terms to fully capture the kinds of variation annotated
by the Ensembl variation pipeline [20]. A requirements
analysis was undertaken to establish the terminology and
relationships between terms to accomplish annotation and
facilitate queries of annotated datasets. Ensembl uses 34
terms [21] to describe the effect of variation, 21 of which
were new to SO, and 2 required an ammendement to
the name. Figure 1 shows a subset of the terms in SO
that describe sequence variants, with the Ensembl terms
highlighted.
In the SO, the sequence alteration and the effects of
the alteration are separated. A sequence alteration de-
fines the nucleotide change observed in an individual se-
quence, in relation to a reference sequence. Examples of
alterations are insertion, deletion, substitution and SNV.
The effect of a sequence alteration is the observed or
predicted change to annotated reference seqeunce fea-
tures. These effects of sequence alterations are defined
as sequence variants in SO and are outlined in Fig. 1.
Examples of these terms are missense variant, wherebysed by Ensembl to annotate the effects od sequence alteration. A
erms used by Ensembl in dark grey. Feature variant terms define cases
rence feature such as a transcript or exon, whereas the kinds of feature
d. Definitions for these terms are available from the miSO browser:
/genome/variation/predicted_data.html
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amino acid would change, and splice donor variant
where by the alteration changes the two-base pair region
at the 5′ end of an intron.
One of the advantages of using an ontology for the an-
notation of data, is that given the related nature of the
terms, there are options to annotate data to the level of
detail afforded by the evidence. Under the sequence vari-
ant node, SO provides two high level nodes in the ontol-
ogy: structural variant and functional variant. Structural
variants pertain to changes with regard to annotated se-
quence features, and are the output of automated variant
effect predition tools such as VEP [3]. Functional variants
however describe the cellular effect of a sequence alter-
ation and are generally manually curated. These functional
terms have largely been absorbed into the Variation ontol-
ogy [22] and are not automatically assigned by variant ef-
fect prediction tools. With regards to structural variants,
the alteration can either internally modify a sequence fea-
ture, when the alteration falls within the extent of a refer-
ence sequence feature such as an exon (feature variant),
or the alteration can be greater than the extent of the se-
quence feature, causing the ablation or amplification of an
entire genomic feature such as a transcript.
The feature variant node in the ontology subsumes
the terms that describe changes internal to genomic fea-
tures such as those affecting genes, transcripts and in-
trons. The majority of the sequence alterations currently
annotated by Ensembl cause feature variants. These fea-
ture variant terms are shown in Fig. 1, where the terms
used in Ensembl annotations are highlighted in dark
grey. There are five subtypes: intergenic variant, geneFig. 2 Treemap of the proportion of variant affect atributed to each kind o
treemap displays hierarchcal data as nested rectangles. In this dataset there
substitution and SNV, each with a different color. For each sequence alterat
rectangle proportional to the number of occrurences of that annotation, an
generated using the IBM Manyeyes tool (http://www-958.ibm.com/)variant, feature truncation, feature elongation and regu-
latory region variant. Of these terms, gene variant has
77 direct and indirect subtypes and includes most of the
terms that describe structural sequence variants caused
by substitutions and small insertions and deletions. This
portion of the SO contains terms with multiple parents,
to allow for effective querying of the annotations. For
example, the term stop retained variant is both a syn-
onymous variant and a terminator codon variant. Users
are thus able to query the Ensembl data for all termin-
ator codon variants or all synonymous variants.
Annotated variants
GVF formated variant genome annotations for 19 organ-
isms, typed using SO are available within the Ensembl
databases [23] and for download (ftp://ftp.ensembl.org/
pub/release-69/variation/gvf/). Included in this set is a
GVF file of 170,853 human variant annotations, with
data from dbSNP [24] and COSMIC [25] using the de-
scribed terminology. There are four kinds of sequence al-
terations reported, corresponding to 158205 SNVs, 7575
deletions, 3097 insertions and 1876 substitutions. There
are 24 kinds of variant_effect reported in the file, and
five kinds of genomic feature affected (mRNA, miRNA,
transcript, primary_transcript and ncRNA). There are
1,485,317 reported variant effects with corresponding
genomic features, as a single alteration may perturb
many annotated genomic features. For example an SNV
may intersect two alternate transcripts, one in an exon,
the other in an intron. Figure 2 shows a tree map of the
proportion of variant effects annotated to each kind of
sequence alteration in this dataset. As can be seen, eachf sequence alteration in Ensembl human GVF dataset (release 69). A
are four kinds of sequence alteration annotated: insertion, deletion,
ion, the annotated variant effects are shown with the size of the
d the count is provided where space permits. The treemap was
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upon the genome features; insertions and deletions
cause more frameshift variants, where as the SNVs and
other substitutions cause more missense variants.
Discussion and conclusions
Detailed annotation of sequence variation is complicated
because reference genome annotations are complex. Genes
may produce multiple transcripts, may overlap each other
on opposite strands, or even be nested within introns of
other genes, therefore a variant may influence multiple
genomic features. Capturing the effect of a sequence alter-
ation on the genomic features with which it intersects is
an important step towards understanding the implication
of the variant sequence. The terminology described here
provides a basis with whch to categorize and define se-
quence variation and the flexibility to annotate the effect
with respect to the feature intersected. This ontology pro-
vides very specific leaf terms, with which to automatically
annotate genomic sequence but also useful mid level terms
for querying.
Future developments to the ontology will include de-
veloping relationships between the sequence variant
terms and the sequence features that are affected. There
has been significant uptake of these variant effect terms
by the genomic variant annotation community. The
UCSC genomic browser uses this termnology in variant
annotation [26] as does the NCBI’s ClinVar data diction-
ary and dbVar database [17]. New terms will be added as
required. New terms and updates to the ontology may
be requested using the term tracker (https://sourcefor-
ge.net/p/song/term-tracker/). Development of the SO is
collaborative, incorporating community discussion via
our mailing list and the term tracker as well as the re-
sults of focused working groups.
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